INDIANAPOLIS, Nov. 8, 2010 /PRNewswire/ -- BioStorage Technologies, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, today announced that the company has appointed Gregory Swanberg to serve as chief executive officer, effective immediately. Dr. F. John Mills, MD, PhD., will transition from his current role as chief executive officer, but will continue his service as chairman of the board.
Mr. Gregory Swanberg joins BioStorage Technologies with more than 25 years of senior management and executive experience leading operational, sales and corporate support teams. His management experience includes directly overseeing the technical delivery of global outsourced services for critical functions in pharmaceutical manufacturing facilities, public and private research centers, hospitals and clinics and data centers. He has provided management and consulting support domestically and globally for companies like Pfizer, Merck, Genentech, Novartis, Eli Lilly, Morgan Stanley, AT&T, Whirlpool and Lexmark. Swanberg most recently served as the managing director of UMS Advisory, a firm focused on outsourcing and operational excellence primarily in the life science sector. Mr. Swanberg holds a bachelor's degree from the University of Kentucky and master's degrees from Georgia Southern University and Northwestern's Kellogg Graduate School of Management.
In announcing the transition, Dr. Mills commented, "We are extremely pleased to have Greg join BioStorage Technologies and we are confident his experience and skill set in building major outsourcing relationships will offer significant benefit to our company and our customers. Greg's strong track record in leading organizations within healthcare, as well as other high-profile industries will provide new avenues of expansion that I'm confident will bring tremendous value to BioStorage Technologies and our customers."